National Institutes of Health: all 11,571 studies

Page 89 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNCT00019552Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerCompletedNCT00019539Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1
• Raloxifene in Preventing Breast Cancer in Premenopausal WomenCompletedNCT00019500Phase 2
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00019487Phase 2
• Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00019461Phase 2
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00019448Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsCompletedNCT00019435Phase 1
• Lobradimil and Carboplatin in Treating Children With Brain TumorsCompletedNCT00019422Phase 2
• Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic LeukemiaWithdrawnNCT00019409Phase 3
• flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell CancerCompletedNCT00019396Phase 2
• Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic MelanomaCompletedNCT00019383Phase 2
• Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation TherapyCompletedNCT00019357Phase 1
• Flavopiridol in Treating Patients With Refractory CancerCompletedNCT00019344Phase 1
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
• Depsipeptide in Treating Patients With Solid TumorsCompletedNCT00019318Phase 1
• Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV InfectionCompletedNCT00019240Phase 2
• Monoclonal Antibody Therapy in Treating Patients With LeukemiaCompletedNCT00019227Phase 1/2
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00019214Phase 1/2
• Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung CancerCompletedNCT00019201Not applicable
• Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00019188Phase 1/2
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic MelanomaCompletedNCT00019175Phase 1
• Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial CancerCompletedNCT00019136Phase 1
• Thalidomide in Treating Patients With HIV-Associated Kaposi's SarcomaCompletedNCT00019123Phase 2
• Vaccine Therapy in Treating Patients With Advanced or Recurrent CancerCompletedNCT00019110Phase 1
• Vaccine Therapy in Treating Patients With Multiple MyelomaCompletedNCT00019097Phase 2
• Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00019084Phase 2
• Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant GliomaCompletedNCT00019071Phase 1
• Radiation Therapy in Treating Patients With GlioblastomaCompletedNCT00019058Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00019032Phase 1
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasCompletedNCT00019019Phase 1
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerCompletedNCT00019006Phase 1
• Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal MethotrexateCompletedNCT00018967Not applicable
• Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's LymphomaCompletedNCT00018954Phase 2
• Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00018941Phase 3
• Parathyroid Hormone Levels in Relation to the Phosphorus Content of MealsCompletedNCT00018135Not applicable
• Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and ControlsStatus unknownNCT00018122
• A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)CompletedNCT00018109Phase 3
• The Genetics of Environmental AsthmaCompletedNCT00018096Not applicable
• Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based RegimenStatus unknownNCT00018083Not applicable
• Identification and Treatment of Feeder Vessels in Macular DegenerationCompletedNCT00018070Phase 1
• Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) DeficiencyCompletedNCT00018018Phase 1
• Study of Brain Control of MovementCompletedNCT00017979
• Brain Excitability During Self-Paced Voluntary MovementsCompletedNCT00017966
• A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright SyndromeCompletedNCT00017927Phase 3
• Transcranial Magnetic Stimulation (TMS) Studies of DystoniaCompletedNCT00017875
• Anti-Interleukin-5 Antibody to Treat Hypereosinophilic SyndromeCompletedNCT00017862Phase 2
• Acupressure to Treat Nausea and Vomiting in HIV/AIDS PatientsCompletedNCT00017823Phase 1
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant WomenCompletedNCT00017797
• Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV DrugsCompletedNCT00017771
• The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering DrugsCompletedNCT00017758Phase 1
• Phenotype/Genotype Correlations in Neuromuscular DisordersCompletedNCT00017745
• Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African AmericansCompletedNCT00017732
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyCompletedNCT00017719Phase 3
• Effectiveness of Primary Care Physicians in Delivering Weight Control CounselingCompletedNCT00017706Not applicable
• Recombinant Human IL-4 Receptor Used in Treatment of AsthmaCompletedNCT00017693Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid LeukemiaCompletedNCT00017472Phase 1
• Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast CancerCompletedNCT00017394Phase 2
• Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00017381Early Phase 1
• Thalidomide and SU5416 in Treating Patients With Metastatic MelanomaCompletedNCT00017316Phase 2
• Atrasentan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00017264Phase 1
• Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00017251Phase 1
• KRN5500 in Treating Patients With Solid TumorsCompletedNCT00017238Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With IrinotecanCompletedNCT00016978Phase 2
• Effects of Dietary Carbohydrate and Fat on HormonesCompletedNCT00016848
• Language Stimuli Screening in ChildrenCompletedNCT00016796
• Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIVCompletedNCT00016783
• Adolescence, Puberty, and Emotion RegulationCompletedNCT00016731
• 1-Octanol to Treat Essential TremorCompletedNCT00016679Phase 1
• Clinical Trial of Propranolol for Seasonal Affective DisorderCompletedNCT00016666Phase 2
• Linkage Study in Familial Pulmonary FibrosisCompletedNCT00016627
• Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected WomenCompletedNCT00016601Not applicable
• Cause and Pathogenesis of Neurometabolic DisordersCompletedNCT00016562
• Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast CancerCompletedNCT00016549Phase 2
• Effects of BufferGel and PRO 2000/5 Gel in MenCompletedNCT00016536Phase 1
• Differences in Brain Processing of First and Second Languages (Korean and English)CompletedNCT00016510
• Adenoidectomy for Otitis Media in 2-3 Year Old ChildrenTerminatedNCT00016497Phase 3
• A Genetic Analysis of Usher Syndrome in Ashkenazi JewsCompletedNCT00016471
• CCI-779 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00016328Phase 2
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00016302Not applicable
• Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00016289Phase 2
• Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTerminatedNCT00016276Phase 3
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate CancerCompletedNCT00016107Phase 2
• S0108 Bevacizumab in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00016094Phase 2
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute LeukemiaCompletedNCT00016016Phase 1/2
• Thalidomide in Treating Patients With Myelodysplastic SyndromeCompletedNCT00015990Phase 2
• Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00015912Phase 2
• STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00015834Phase 1/2
• Thalidomide in Treating Patients With MyelofibrosisCompletedNCT00015821Phase 2
• Safety Study of Idebenone to Treat Friedreich's AtaxiaCompletedNCT00015808Phase 1
• Study of Air Stream in Voice ProductionCompletedNCT00015795Phase 1
• The Natural History and Pathogenesis of Mucolipidosis Type IVCompletedNCT00015782
• Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar IllnessCompletedNCT00015769Phase 2
• Tissue Collection From People With Cystic FibrosisCompletedNCT00015756
• Magnetic Resonance Imaging to Investigate Silent Strokes During Neck and Skull AngioplastyCompletedNCT00015717
• Effect of Interleukin-2 on HIV Treatment InterruptionCompletedNCT00015704Not applicable
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat AbnormalitiesCompletedNCT00015691Not applicable
• Effects of Flumazenil on Brain ExcitabilityCompletedNCT00015678
• Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal InfectionsCompletedNCT00015665Phase 3
• Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionCompletedNCT00015652Not applicable

← National Institutes of Health overview and focus areas